Search Results
You are looking at 1 - 1 of 1 items for
- Author: D. J. Phillips x
- Refine by access: Open Access content only x
Search for other papers by Shiao Y Chan in
Google Scholar
PubMed
Search for other papers by Laura A Hancox in
Google Scholar
PubMed
Search for other papers by Azucena Martín-Santos in
Google Scholar
PubMed
Search for other papers by Laurence S Loubière in
Google Scholar
PubMed
Search for other papers by Merlin N M Walter in
Google Scholar
PubMed
Search for other papers by Ana-Maria González in
Google Scholar
PubMed
Search for other papers by Phillip M Cox in
Google Scholar
PubMed
Search for other papers by Ann Logan in
Google Scholar
PubMed
Search for other papers by Christopher J McCabe in
Google Scholar
PubMed
Search for other papers by Jayne A Franklyn in
Google Scholar
PubMed
School of Clinical and Experimental Medicine, Department of Pathology, Fetal Medicine Centre, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
Search for other papers by Mark D Kilby in
Google Scholar
PubMed
The importance of the thyroid hormone (TH) transporter, monocarboxylate transporter 8 (MCT8), to human neurodevelopment is highlighted by findings of severe global neurological impairment in subjects with MCT8 (SLC16A2) mutations. Intrauterine growth restriction (IUGR), usually due to uteroplacental failure, is associated with milder neurodevelopmental deficits, which have been partly attributed to dysregulated TH action in utero secondary to reduced circulating fetal TH concentrations and decreased cerebral thyroid hormone receptor expression. We postulate that altered MCT8 expression is implicated in this pathophysiology; therefore, in this study, we sought to quantify changes in cortical MCT8 expression with IUGR. First, MCT8 immunohistochemistry was performed on occipital and parietal cerebral cortex sections obtained from appropriately grown for gestational age (AGA) human fetuses between 19 weeks of gestation and term. Secondly, MCT8 immunostaining in the occipital cortex of stillborn IUGR human fetuses at 24–28 weeks of gestation was objectively compared with that in the occipital cortex of gestationally matched AGA fetuses. Fetuses demonstrated widespread MCT8 expression in neurons within the cortical plate and subplate, in the ventricular and subventricular zones, in the epithelium of the choroid plexus and ependyma, and in microvessel wall. When complicated by IUGR, fetuses showed a significant fivefold reduction in the percentage area of cortical plate immunostained for MCT8 compared with AGA fetuses (P<0.05), but there was no significant difference in the proportion of subplate microvessels immunostained. Cortical MCT8 expression was negatively correlated with the severity of IUGR indicated by the brain:liver weight ratios (r 2=0.28; P<0.05) at post-mortem. Our results support the hypothesis that a reduction in MCT8 expression in the IUGR fetal brain could further compromise TH-dependent brain development.
